Traveling for Care?
Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (SKCCC) is an NCI designated Cancer Center. NCI designated Cancer Centers are required to review the scientific aspects of all cancer-related clinical research being done at the Institution. The Clinical Research Review Committee (CRC) was established for this purpose.
The CRC is charged with the pre-review of the scientific merit, priorities, and progress of all clinical research involving cancer patients.
In order to ensure compliance with the NCI’s guidelines, the following process is conducted for NEW applications:
An application received by the Office of Human Subjects Research may not be marked correctly in Section 30. If OHSR staff or the IRB should determine that CRC review is required, the application will be returned to the PI for correction. Once section 30 is completed, the submission process to the CRC will occur.
Process for CRC review of continuing review applications: In addition to the review of a new application, the CRC is required to conduct a continuing review of the scientific progress of all therapeutic cancer trials. The CRC review process occurs at the time of the scheduled IRB continuing review process. The CRC will provide to the IRB any significant findings that it believes affects the continued conduct of the study.
The CRC meets weekly to review applications. The CRO staff is located in Room 1101 in the 550 Building and may be reached at (410) 955-8866. They can provide details regarding the CRC’s review requirements and time frame estimates for completing their review.
For more information please visit the CRO website or call (410) 955-8866.